Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

4.9%

3 terminated/withdrawn out of 61 trials

Success Rate

89.7%

+3.2% vs industry average

Late-Stage Pipeline

8%

5 trials in Phase 3/4

Results Transparency

8%

2 of 26 completed trials have results

Key Signals

10 recruiting2 with results

Enrollment Performance

Analytics

N/A
29(80.6%)
Phase 4
5(13.9%)
Early Phase 1
1(2.8%)
Phase 2
1(2.8%)
36Total
N/A(29)
Phase 4(5)
Early Phase 1(1)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (61)

Showing 20 of 61 trials
NCT07488052Recruiting

Home-based Outpatient Multicenter Evaluation Using Electrocardiogram (HOME-ECG)

Role: collaborator

NCT07472803Recruiting

Longitudinal Body Composition Assessment in Breast Cancer Patients

Role: lead

NCT04496882Phase 4Active Not Recruiting

Chronic Hepatitis b Patients Switch to tAf After Discontinuation of Nucleoside Analogue

Role: collaborator

NCT07357142Not ApplicableNot Yet Recruiting

Jing Si Herbal Tea as Adjuvant Treatment in Patients With Chronic Pelvic Pain Syndrome

Role: lead

NCT06620328Not ApplicableRecruiting

Safety and Efficacy of Mechanical Versus Electrocautery Dilator for EUS-guided Biliary Drainage (MED-BD)

Role: collaborator

NCT07310797Phase 4Not Yet Recruiting

Comparison of Mirabegron and Tamsulosin for Ureteral Stone Expulsion

Role: lead

NCT07185659Not ApplicableRecruiting

The Effect of Walking Exercise in Patients With Chronic Obstructive Pulmonary Disease

Role: lead

NCT04525833Recruiting

Liver Disease and Other Systemic Diseases

Role: lead

NCT07151963Not ApplicableEnrolling By Invitation

Effects of Prolonged Continuous Theta Burst Stimulation in Chemotherapy-induced Peripheral Neuropathy

Role: lead

NCT05739071Not ApplicableEnrolling By Invitation

JING SI HERBAL TEA and Urinary Tract Symptoms in Bladder Cancer

Role: lead

NCT07096180Recruiting

Clinical Observational Studies:Integrative TCM and Western Medicine for Breast Cancer

Role: lead

NCT05997992Not ApplicableRecruiting

Clinical Efficacy Evaluation of Electroacupuncture as Adjuvant Therapy for Female Patients With Overactive Bladder

Role: lead

NCT06901557Not ApplicableCompleted

Benefits of Jing-Si-Herbal-Tea in Bronchiectasis

Role: lead

NCT06869382Phase 4Completed

ICS+LABA Vs. ICS+LABA+Omalizumab: Impact on Asthma Control and Gene Expression

Role: lead

NCT05782972Phase 4Active Not Recruiting

Therapeutic Response of Sodium-glucose Co-transporter Type-2 Inhibitor in Non-diabetic MAFLD Patients: a Pilot Study

Role: lead

NCT05492175Not ApplicableRecruiting

Proximal- Versus Distal-Prioritized Robotic Practice Plus Kinetic Exergaming in Stroke Rehabilitation

Role: lead

NCT06448871Completed

Ultrasound to Assess Sarcopenia in Prader Willi Syndrome

Role: lead

NCT06584786Early Phase 1Recruiting

Therapeutic Effects of Jing Si Herbal Tea for COPD

Role: lead

NCT06428942Not ApplicableRecruiting

Low-potassium Content Vegetables in Chronic Kidney Disease

Role: lead

NCT06401265Completed

Recalling the Treatment and Prognosis of Upper Tract Urothelial Cancer (UTUC)

Role: lead